Zamuner S - Search Results

1

Population modelling of patient responses in antidepressant studies: a stochastic approach.

Marostica E, Russu A, Gomeni R, Zamuner S, De Nicolao G. Marostica E, et al. Among authors: zamuner s. Math Biosci. 2015 Mar;261:37-47. doi: 10.1016/j.mbs.2014.11.007. Epub 2014 Dec 4. Math Biosci. 2015. PMID: 25481225

2

A PCA approach to population analysis: with application to a Phase II depression trial.

Marostica E, Russu A, Gomeni R, Zamuner S, De Nicolao G. Marostica E, et al. Among authors: zamuner s. J Pharmacokinet Pharmacodyn. 2013 Apr;40(2):213-27. doi: 10.1007/s10928-013-9304-6. Epub 2013 Mar 17. J Pharmacokinet Pharmacodyn. 2013. PMID: 23504512 Clinical Trial.

3

Population model of longitudinal FEV1 data in asthmatics: meta-analysis and predictability of placebo response.

Marostica E, Russu A, Yang S, De Nicolao G, Zamuner S, Beerahee M. Marostica E, et al. Among authors: zamuner s. J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):553-69. doi: 10.1007/s10928-014-9373-1. Epub 2014 Aug 15. J Pharmacokinet Pharmacodyn. 2014. PMID: 25123552

4

Continuous-time Markov modelling of flexible-dose depression trials.

Marostica E, Russu A, Gomeni R, Zamuner S, De Nicolao G. Marostica E, et al. Among authors: zamuner s. J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):625-38. doi: 10.1007/s10928-014-9389-6. Epub 2014 Oct 4. J Pharmacokinet Pharmacodyn. 2014. PMID: 25281421

5

Joint modeling of efficacy, dropout, and tolerability in flexible-dose trials: a case study in depression.

Russu A, Marostica E, De Nicolao G, Hooker AC, Poggesi I, Gomeni R, Zamuner S. Russu A, et al. Among authors: zamuner s. Clin Pharmacol Ther. 2012 May;91(5):863-71. doi: 10.1038/clpt.2011.322. Clin Pharmacol Ther. 2012. PMID: 22472989 Clinical Trial.

6

Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patients.

Bizzotto R, Zamuner S, De Nicolao G, Karlsson MO, Gomeni R. Bizzotto R, et al. Among authors: zamuner s. J Pharmacokinet Pharmacodyn. 2010 Apr;37(2):137-55. doi: 10.1007/s10928-009-9148-2. Epub 2010 Jan 6. J Pharmacokinet Pharmacodyn. 2010. PMID: 20052524 Clinical Trial.

7

A pharmacokinetic PET study of NK₁ receptor occupancy.

Zamuner S, Rabiner EA, Fernandes SA, Bani M, Gunn RN, Gomeni R, Ratti E, Cunningham VJ. Zamuner S, et al. Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):226-35. doi: 10.1007/s00259-011-1954-2. Epub 2011 Oct 13. Eur J Nucl Med Mol Imaging. 2012. PMID: 21993526

8

Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysis.

Bizzotto R, Zamuner S, Mezzalana E, De Nicolao G, Gomeni R, Hooker AC, Karlsson MO. Bizzotto R, et al. Among authors: zamuner s. AAPS J. 2011 Sep;13(3):445-63. doi: 10.1208/s12248-011-9287-4. Epub 2011 Jun 21. AAPS J. 2011. PMID: 21691915 Free PMC article.

9

Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist.

Bettica P, Nucci G, Pyke C, Squassante L, Zamuner S, Ratti E, Gomeni R, Alexander R. Bettica P, et al. Among authors: zamuner s. J Psychopharmacol. 2012 Aug;26(8):1058-70. doi: 10.1177/0269881111408954. Epub 2011 Jul 5. J Psychopharmacol. 2012. PMID: 21730017 Clinical Trial.

10

MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues.

Lavezzi SM, Mezzalana E, Zamuner S, De Nicolao G, Ma P, Simeoni M. Lavezzi SM, et al. Among authors: zamuner s. J Pharmacokinet Pharmacodyn. 2018 Dec;45(6):787-802. doi: 10.1007/s10928-018-9608-7. Epub 2018 Nov 10. J Pharmacokinet Pharmacodyn. 2018. PMID: 30415351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters